End-of-day quote
Other stock markets
|
||
- | - |
|
27/06 | BMO Initiates Neurogene at Outperform With $65 Price Target | MT |
18/06 | Neurogene Doses First Patient in High-Dose Group of Rett Syndrome Trial | MT |